The binary eutectic of NSAIDs and two-phase liquid system for enhanced membrane permeation

Pharmaceutical Development and Technology

Volumn 10, Issue 1, 2005, Pages 1-10

  Yuan, Xudong ^a   Capomacchia, A C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Binary eutectic; Enhanced membrane permeation; Ibuprofen; Isopropyl alcohol; Ketoprofen; NSAIDs; Transdermal drug delivery

Indexed keywords

2 PROPANOL; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL; PIROXICAM; SALICYLIC ACID;

AQUEOUS SOLUTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG PENETRATION; ENVIRONMENTAL TEMPERATURE; LIQUID; MELTING POINT; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SKIN; SNAKE; THERMODYNAMICS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CELL MEMBRANE PERMEABILITY; CHEMISTRY, PHARMACEUTICAL; KETOPROFEN; PERMEABILITY; SKIN; SNAKES;

EID: 14644392261     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-200035859     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention (CDC). The National Arthritis Action Plan: A Public Health Strategy (NAAP); National Center for Chronic Disease Prevention and Health Promotion: Atlanta, GA, USA, 2002.
2. Cryer, B. NSAID gastrointestinal toxicity. Curr. Opin. Gastroenterol. 2000, 16 (6), 495-502.
3. Brodin, A.; Nyqvist-Mayer, A.; Wadsten, T.; Forslund, B.; Broberg, F. Phase diagram and aqueous solubility of the lidocaine-prilocaine binary system. J. Pharm. Sci. 1984, 73, 481-484.
4. Nyqvist-Mayer, A.A.; Brodin, A.F.; Frank, S.G. Phase distribution studies on an oil-water emulsion based on eutectic mixture of lidocaine and prilocaine as the dispersed phase. J. Pharm. Sci. 1985, 74, 1192-1195.
5. Heyneman, C.A.; Lawless-Liday, C.; Wall, G.C. Oral versus topical NSAIDs in rheumatic diseases - a comparison. Drugs 2000, 60 (3), 555-574.
6. Taburet, A.M.; Singlas, E.; Glass, R.C.; Thomas, F.; Leutenegger, E. Pharmacokinetic comparison of oral and local-action transcutaneous flurbiprofen in healthy-volunteers. J. Clin. Pharm. Ther. 1995, 20 (2), 101-107.
7. Treffel, P.; Gabard, B. Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay. Skin Pharmacol. 1993, 6 (4), 268-275.
8. Calpena, A.C.; Blanes, C.; Moreno, J.; Obach, R.; Domenech, J. A comparative in vitro study of transdermal absorption of anti-emetics. J. Pharm. Sci. 1994, 83, 29-33.
9. Kasting, G.B.; Smith, R.L.; Cooper, E.R. Effects of lipid solubility and molecular size on percutaneous absorption. Pharmacol. Skin 1987, 1, 138-153.
10. Yalkowski, S.H.; Valvani, S.C. Solubility and partitioning. I. Solubility of nonelectrolytes in water. J. Pharm. Sci. 1980, 69, 912-922.
11. Touitou, E.; Chow, D.D.; Lawter, J.R. Chiral beta-blockers for transdermal delivery. Int. J. Pharm. 1994, 104, 19-28.
12. Grant, D.; Abougela, I. Physico-chemical interactions in pharmaceutical formulations. Anal. Proc. 1982, 19, 545-549.
13. Ford, J.L.; Timmins, P. Pharmaceutical Thermal Analysis; John Wiley and Sons: New York, 1989; 47-67.
14. Higuchi, T.; Konishi, R. In vitro testing and transdermal delivery. Ther. Res. 1987, 6, 280-288.
15. Itoh, T.; Xia, J.; Magavi, R.; Nishihata, T.; Rytting, J.H. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm. Res. 1990, 7, 1042-1047.
16. Zhang, G.G.Z.; Paspal, S.Y.L.; Suryanarayanan, R.; Grant, D.J.W. Racemic species of sodium ibuprofen: characterization and polymorphic relationships. J. Pharm. Sci. 2003, 92 (7), 1356-1366.
17. Bansal, P.; Haribhakti, K.; Subramanian, V.; Plakogiannis, F. Effect of formulation and process variables on the dissolution profile of naproxen sodium from tablets. Drug Dev. Ind. Pharm. 1994, 20 (13), 2151-2156.
18. Henck, J.O.; Kuhnert-Brandstatter, M. Demonstration of the terms enantiotropy and monotropy in polymorphism research exemplified by flurbiprofen. J. Pharm. Sci. 1999, 88 (1), 103-108.
19. Lacoulonche, F.; Chauvet, A.; Masse, J. An investigation of flurbiprofen polymorphism by thermoanalytical and spectroscopic methods and a study of its interactions with poly-(ethylene glycol) 6000 by differential scanning calorimetry and modeling. Int. J. Pharm. 1997, 153 (2), 167-179.